塔罗利丁诱导的严重过敏反应
Lisa Christina Horvath1, Gottfried Heinz2, Christine Bangert3
1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Kidney medicine
|October 6, 2025
概括
陶罗利丁可以引起严重的过敏反应,即危及生命的过敏反应,即使用作导管锁液. 这一案例凸显了对耐火性过敏性休克的新疗法的需求.
科学领域:
- 医学 医学 医学 医学 医学
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 基于陶罗利丁的溶液在中央静脉导管中很常见.
- 虽然已知轻微反应,但严重的过敏反应未经记录.
研究的目的:
- 为了报告一种罕见的,可能危及生命的过敏反应,这种过敏反应是由taurolidine引起的.
- 为了突出治疗耐火性过敏性休克的挑战.
主要方法:
- 一个59岁的男性意外输入静脉注射taurolidine的案例报告.
- 重症监护病房管理,包括血管压缩器.
- 门诊过敏工作与皮肤刺伤测试.
主要成果:
- 患者经历了严重的过敏性休克,对标准上腺素治疗有抗性.
- 需要额外的血管压缩剂 (上腺素,血管压缩剂).
- 皮肤刺刺测试证实了taurolidine过敏. 皮肤刺刺测试证实了taurolidine过敏.
结论:
- 塔罗利丁可以诱导严重的,长时间的过敏性休克.
- 对于耐火病例,传统的治疗方法可能不足.
- 对过敏反应的新型治疗策略是必要的.
相关概念视频
Allergic Reactions
32.0K
Overview
32.0K
Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
Local Anesthetics: Adverse Effects
754
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
754
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
599
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
599


